Welcome to LookChem.com Sign In|Join Free

CAS

  • or

65488-05-3

Post Buying Request

65488-05-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

65488-05-3 Usage

General Description

1-Butanone, 4-iodo-1-phenyl is a chemical compound that belongs to the family of ketones. It is primarily used as an intermediate in the production of pharmaceuticals, agrochemicals, and fine chemicals. 1-Butanone, 4-iodo-1-phenyl is also used as a reagent in organic synthesis and as a solvent in various chemical reactions. It is a colorless liquid with a strong odor and is flammable. It is important to handle this chemical with caution as it may cause irritation to the skin, eyes, and respiratory system upon exposure. Additionally, it should be stored in a cool, dry, well-ventilated area away from sources of heat and ignition.

Check Digit Verification of cas no

The CAS Registry Mumber 65488-05-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,5,4,8 and 8 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 65488-05:
(7*6)+(6*5)+(5*4)+(4*8)+(3*8)+(2*0)+(1*5)=153
153 % 10 = 3
So 65488-05-3 is a valid CAS Registry Number.

65488-05-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name phenyl 3-iodopropyl ketone

1.2 Other means of identification

Product number -
Other names 4-iodo-1-phenylbutan-1-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:65488-05-3 SDS

65488-05-3Relevant articles and documents

Visible-light-enhanced ring opening of cycloalkanols enabled by br?nsted base-tethered acyloxy radical induced hydrogen atom transfer-electron transfer

Zhao, Rong,Yao, Yuan,Zhu, Dan,Chang, Denghu,Liu, Yang,Shi, Lei

supporting information, p. 1228 - 1231 (2018/02/23)

A metal-free ring opening/halogenation of cycloalkanols, which combines both PPO/TBAX oxidant system and blue LEDs irradiation, is presented. This method produces diverse γ, α, and even more remotely halogenated ketones in moderate to excellent yields under mild conditions. Interestingly, experimental and computational studies demonstrate the novel ring size-dependent concerted/stepwise (four-/five- to eight-membered rings) hydrogen atom transfer-electron transfer induced by Br?nsted base-tethered acyloxy radical, which indicates distinct advantages brought by the cyclic structure of diacyl peroxides.

Catalytic asymmetric intramolecular homologation of ketones with α-diazoesters: Synthesis of cyclic α-Aryl/Alkyl β-ketoesters

Li, Wei,Tan, Fei,Hao, Xiaoyu,Wang, Gang,Tang, Yu,Liu, Xiaohua,Lin, Lili,Feng, Xiaoming

supporting information, p. 1608 - 1611 (2015/01/30)

A catalytic asymmetric intramolecular homologation of simple ketones with α-diazoesters was firstly accomplished with a chiral N,N′-dioxide-Sc(OTf)3 complex. This method provides an efficient access to chiral cyclic α-aryl/alkyl β-ketoesters containing an all-carbon quaternary stereocenter. Under mild conditions, a variety of aryl- and alkyl-substituted ketone groups reacted with α-diazoester groups smoothly through an intramolecular addition/rearrangement process, producing the β-ketoesters in high yield and enantiomeric excess.

D2 ANTAGONISTS, METHODS OF SYNTHESIS AND METHODS OF USE

-

Page/Page column 104, (2012/01/06)

Provided are D2 or D3 antagonist compounds and pharmaceutical compositions of formula I and pharmaceutically acceptable salts thereof, or isomers thereof, wherein R1, R2 and R3 are as defined herein. The invention further comprises methods for making the compounds of the invention and methods for the treatment of conditions mediated by the dopamine D2 or D3 receptor from the compounds of the invention.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 65488-05-3